Search

Highly efficient isomerization of glucose to fructose is essential for valorizing cellulose fraction of biomass to value-added chemicals. This work provided an innovative method for preparing Mg-biochar and Mg–K-biochar catalysts by impregnating either MgCl2 alone or in combination with different K compounds (Ding et al. in Bioresour Technol 341:125835, 2021, https://doi.org/10.1016/j.biortech.2021.125835 and KHCO3) on cellulose-derived biochar, followed by hydrothermal carbonization and pyrolysis. Single active substance MgO existing in the 10Mg–C could give better catalytic effect on glucose isomerization than the synergy of MgO and KCl crystalline material present in 10Mg–KCl–C. But the catalytic effect of 10Mg–C was decreased when the basic site of MgO was overloaded. Compared to other carbon-based metal catalysts, 10Mg–KHCO3–C with 10 wt% MgCl2 loading had excellent catalytic performance, which gave a higher fructose yield (36.7%) and selectivity (74.54%), and catalyzed excellent glucose conversion (53.99%) at 100 °C in 30 min. Scanning electron microscope–energy dispersive spectrometer and X-Ray diffraction revealed that the distribution of Mg2+ and K+ in 10Mg–KHCO3–C was uniform and the catalytic active substances (MgO, KCl and K2CO3) were more than 10Mg–C (only MgO). The synergy effects of MgO and K2CO3 active sites enhanced the pH of reaction system and induced H2O ionization to form considerable OH− ions, thus easily realizing a deprotonation of glucose and effectively catalyzing the isomerization of glucose. In this study, we developed a highly efficient Mg–K-biochar bimetallic catalyst for glucose isomerization and provided an efficient method for cellulose valorization. Highlights: The bimetallic Brønsted catalyst designed in this study (10Mg–KHCO3–C) could achieve high fructose yield (36.7%) and selectivity (74.54%). The MgO could give obtain good catalytic effect on glucose isomerization, but the catalytic effect decreased when the Mg+ was overloaded. The synergy effects of MgO and K2CO3 could enhance the pH of reaction system and effectively catalyze the isomerization of glucose. [ABSTRACT FROM AUTHOR]

Loops are critical elements in boundary representation (B-rep) models because they link all edges corresponding to a face. Loops can be used in feature recognition for identifying depressions or protrusions. In real 3D CAD models, however, features typically lie across multiple faces, which is beyond the data structure of current B-rep models. This study presents a virtual loop concept to account for all loop types used in CAD models, and develops algorithms for recognizing them. In accordance with the complexity of the recognition algorithm, this study defines three types of loop: single, virtual, and multivirtual. A single loop is the current loop recorded in the B-rep model. A virtual loop lies across faces that are at least G continuous. Finally, a multivirtual loop lies across faces that are either G or G continuous. The proposed loop structure provides a more complete data structure for recognizing various types of features in feature-recognition modules. Several realistic CAD models are presented to confirm the feasibility of the proposed loop-recognition and feature-recognition methods. [ABSTRACT FROM AUTHOR]

Eosinophil granule ontogeny transcript ( EGOT) is a long noncoding RNA involved in the regulation of eosinophil granule protein transcript expression. However, little is known about the role of EGOT in malignant disease. This study aimed to assess the potential role of EGOT in the pathogenesis of breast cancer. Quantitative real-time polymerase chain reaction was performed to detect the expression levels of EGOT in 250 breast cancerous tissues and 50 adjacent noncancerous tissues. The correlation of EGOT expression with clinicopathological features and prognosis was also analyzed. EGOT expression was lower in breast cancer compared with the adjacent noncancerous tissues ( P < 0.001), and low levels of EGOT expression were significantly correlated with larger tumor size ( P = 0.022), more lymph node metastasis ( P = 0.020), and higher Ki-67 expression ( P = 0.017). Moreover, patients with low levels of EGOT expression showed significantly worse prognosis for overall survival ( P = 0.040), and this result was further validated in a larger cohort from a public database. Multivariate analysis suggested that low levels of EGOT were a poor independent prognostic predictor for breast cancer patients (HR = 1.857, 95 % CI = 1.032-3.340, P = 0.039). In conclusion, EGOT may play an important role in breast cancer progression and prognosis and may serve as a new potential prognostic target in breast cancer patients. [ABSTRACT FROM AUTHOR]

A leucine aminopeptidase Lap1 was cloned from Aspergillus sojae GIM3.30. The truncated Lap1 without a signal peptide was over-expressed in P. pastoris, and the enzymatic characteristics of recombinant Lap1 (rLap1) were tested. The rLap1 was about 36.7 kDa with an optimal pH 8.0 and optimal temperature 50 °C for substrate Leu-p-nitroanilide and it sustained 50 % activity after 1 h incubation at 50 °C. The activity of rLap1 was significantly inhibited by EDTA, whereas Co, Mn, and Ca ions, but not Zn ions, restored its activity. rLap1 showed the highest activity against Arg-pNA and then Leu-, Lys-, Met-, and Phe-pNA. The 3D structure of rLap1 showed it had a conserved functional charge/dipole complex and a hydrogen bond network of Zn2-D179-S228-Q177-D229-S158 around its active center. An acidic Asp residue was found at the bottom of the substrate binding pocket, which explains its preference for basic N-terminal amino acid substrates such as Arg and Lys. rLap1 improved the degree of hydrolysis of casein and soy protein hydrolysates and also decreased their bitterness, indicating its potential utility in food production. [ABSTRACT FROM AUTHOR]

The discrete element method was used to investigate the microscopic characteristics of granular materials under simple shear loading conditions. A series of simple tests on photo-elastic materials were used as a benchmark. With respect to the original experimental observations, average micro-variables such as the shear stress, shear strain and the volumetric dilatancy were extracted to illustrate the performance of the DEM simulation. The change of anisotropic density distributions of contact normals and contact forces was demonstrated during the course of simple shear. On the basis of microscopic characteristics, an analytical approach was further used to explore the macroscopic behaviors involving anisotropic shear strength and anisotropic stress-dilatancy. This results show that under simple shear loading, anisotropic shear strength arises primarily due to the difference between principal directions of the stress and the fabric. In addition, non-coaxiality, referring to the difference between principal directions of the strain rate and the stress, generates less stress-dilatancy. In particular, the anisotropic hardening and anisotropic stress-dilatancy will reduce to the isotropic hardening and the classical Taylor's stress-dilatancy under proportional loading. [ABSTRACT FROM AUTHOR]

Dihydroartemisinin, formerly known as an antimalarial drug, is the main metabolite of the mother compound artemisinins, as well as of artemether and artesunate. It has been shown that the drug exhibits antischistosomal efficacy against Schistosoma japonicum. The purpose of the current study was to assess the in vivo effect of dihydroartemisinin against Schistosoma mansoni infection in mice. Drugs at a single oral dose of 300 mg/kg were given to mice to assess the efficacy against different developmental stages of the parasite; juvenile and adult S. mansoni were treated with single doses of dihydroarteminisin with different regimens (at 200, 300, 400 or 600 mg/kg) in the stage of drug sensitivity, and the dose-response relationship was assessed; and the effect of multiple doses (at 200, 300 or 400 mg/kg) on juvenile and adult S. mansoni was also observed. The results showed that a single oral dose (300 mg/kg) of dihydroartemisinin reduced total worm burdens by 13.8-82.1% and female worm burdens by 13-82.8%, and the greatest reductions were seen when treatment was given on day 21 post-infection, with total and female worm burden reductions of 82.1% and 82.8%. Administration of a single oral dose of dihydroartemisinin on day 21 post-infection with different drug dosage (at 200, 300, 400 or 600 mg/kg) reduced total worm burdens by 70.3-87.3% and female worm burdens by 73.5-92.4%, depending on dosage. Similar treatments given on day 49 post-infection reduced total worm burdens by 48.7-68.73% and female worm burdens by 63.25-94.6%. There was obvious dose-response relationship of dihydroartemisinin against the schistosomula and adult worms of S. mansoni observed. Administration with dihydroartemisinin at oral doses of 200, 300 and 400 mg/kg, given once on each of days 20-22 post-infection of three successive days, reduced total worm burdens by 88.5-90.1% and female worm burdens by 89.2-92.1%, depending on dosage. Similar treatments given once on each of days 48-50 post-infection reduced total worm burdens by 60-70.3% and female worm burdens by 77.5-94.9%. It is concluded that dihydroartemisinin exhibits in vivo activity against various developmental stages of S. mansoni, particularly the 21-day schistosomula, and there is obvious dose-response relationship of dihydroartemisinin against the schistosomula and adult worms of S. mansoni observed. [ABSTRACT FROM AUTHOR]

emether and artesunate, derivatives of the antimalarial artemisinin, as well as their main metabolite, dihydroartemisinin, all exhibit antischistosomal activities. The purpose of the current study was to compare the effects of artemether, artesunate and dihydroartemisinin administered orally at multiple doses or combination in treatment of mice infected with Schistosoma japonicum. We carried out experiments with mice, infected with 40 cercariae of S. japonicum, and treated with artemether, aretesunate and dihydroartemisinin (all at a single dose of 300 mg/kg, and the dose of the mixed three drugs is also 300 mg/kg) at multiple doses or combination therapy on days 6-8 or 34-36 post-infection. Administration with artemether, artesunate or dihydroartemisinin for 3 successive days reduced total worm burdens by 79.5−86% (30.86 ± 4.98 of mean total worm burden in control), female worm burdens by 79.4−86.7% (11.29 ± 2.63 of mean female worm burden in control) (all P values <0.01 vs. control), depending on different treatment protocols given on days 6-8 post-infection. However, no differences were seen between each treatment group (all P > 0.05). While the same treatment was given on days 34-36 post-infection, total worm burden reductions of 73.8−75.8% were achieved (29.44 ± 3.36 of mean total worm burden in control), which were significant when compared with the untreated control group (all P values <0.01). In all different treatment groups, female worm reductions (ranging from 88.7% to 93.1%, while the mean female worm burden in control is 10.33 ± 1.80) were consistently higher than the total worm reductions, resulting always in significantly lower female worm burdens when compared to the corresponding control (all P values < 0.01). However, there were no significant differences found between each treatment group (all P values >0.05). It is concluded that artemether, artesunate and dihydroartemisinin can be used to control schistosomiasis japonica, as a strategy to prevent S. japonicum infection. Administration with artemether, artesunate and dihydroartemisinin at multiple doses or in combined treatment damages both juvenile and adult S. japonicum, without statistically significant differences among the three drugs at the same dose. [ABSTRACT FROM AUTHOR]

Copyright of Neuroscience Bulletin is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)